Navigation Links
Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
Date:7/7/2009

LONDON, July 7 /PRNewswire/ -- The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix(R) is highly effective at protecting against the two most common cervical cancer-causing human papillomavirus (HPV) types, 16 and 18. The study also showed that the vaccine provides cross-protection against HPV types 31, 33 and 45, the three most common cancer-causing virus types beyond 16 and 18.

Thomas Breuer, Head of Global Clinical R&D and Chief Medical Officer of GSK Biologicals commented: "These excellent study results confirm the efficacy offered by Cervarix(R) against HPV 16 and 18. For the first time the results show that this vaccine was effective against cervical pre-cancers associated with the five most common cancer-causing virus types. This is really good news for primary prevention of cervical cancer as it indicates the vaccine could offer women additional protection against cervical cancer beyond what had at first been anticipated."

The study showed that in women who complied with the trial protocol procedures (87% of the total sample), the vaccine provided 92.9 percent protection against cervical pre-cancers (cervical intraepithelial neoplasia 2+ or CIN 2+) associated with HPV 16 or 18. A further analysis of the same cohort which excluded lesions not likely to be caused by HPV 16 and 18 revealed that the vaccine was 98.1 percent effective against cervical pre-cancers (CIN 2+) caused by these two types.

The study showed -- for the first time for any cervical cancer vaccine -- that Cervarix(R) provided significant cross-protection against pre-cancerous lesions not containing HPV types 16 and/or 18. This additional efficacy could translate into approximately 11-16 percent extra protection against cervical cancer over and above the protection afforded
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
2. Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
3. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
4. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing
7. Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
8. Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
9. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
10. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
11. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... LOVELAND, Colo. , May 24, 2013  Heska Corporation ... veterinary diagnostic and specialty products, announced today that Dr. ... executive officer, and Jason Napolitano , executive ... Second Annual Marcum MicroCap Conference, which is being held May ... at the Grand Hyatt Hotel. The Company,s ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... 2013 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... President and Chief Executive Officer of Neurocrine Biosciences, will be ... Health Care Conference in Boston.   The live ... Eastern Time / 8:20 a.m. Pacific Time.  The presentation will ... at http://www.neurocrine.com . If you are ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... is pleased to announce that Dr. Andrea Zobel has ... CTD Operations.  In this capacity she will assume responsibility ... operated Clinical Trial Depots once they are ... relationship with their affiliate depot network. (Logo:  ...
... 2012 What:   Life Technologies Unveils ... (CES) in Las Vegas.  The Ion Proton™ Sequencer is designed ... When:   Tuesday, January 10th thru Friday, ... Where:   Las Vegas Convention Center, North Hall, Booth #3438 ...
Cached Medicine Technology:Marken Strengthens Clinical Trial Distribution Capabilities 2
(Date:5/25/2013)... This week idcloak Technologies releases a list of IP ... the site is blocked. When IP proxies are used ... site compatibility problems associated with regular proxy sites. Gill-Chris Welles, ... may apply IP Port proxies to create a proxy ... are. , “When a user takes an IP address and ...
(Date:5/25/2013)... Mansfield, MA (PRWEB) May 25, 2013 Imagine ... long -- the energy loss, hot air and wasted energy! ... whole house fan, a fireplace or clothes dryer, that may ... , Drafts from these often overlooked holes waste energy in ... source of heating and cooling loss in the home. , ...
(Date:5/25/2013)... It's not astonishing that holidays are amongst the most ... from family, friends and co-workers. Between the parties to ... their parents can afford, parties to arrange, and so ... anniversaries and it seems like an eternal cycle of ... and income can’t catch up to the expenses of ...
(Date:5/25/2013)... 25, 2013 An experienced Chandler dentist ... partnership with JD Media Surge, LLC. , ... available and, depending on the treatment, can be performed ... visit, the best method will be chosen for the ... a visit. A special peroxide-based whitening gel is used ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2
... exercises, quits smoking, stops drinking alcohol, receives a flu shot, ... likely to do the same, according to a new study ... spouse improves his or her health behavior, the other spouse ... Sindelar, health economist and public health professor in the Yale ...
... be sharply divided in their views on many aspects of ... strong agreement when it comes to one of the most ... to results of the American College of Surgeons (ACS) new ... the establishment of a nationwide trauma system - including strong ...
... Oct. 3 SearchMedica.com, the,specialty-oriented professional medical ... of Family Physicians, Scientific Assembly that it ... medicine and family,practitioners to sort results by ... most relevant professional medical information, it now ...
... pregnant women consuming a typical,western diet obtain too little ... is critical for fetal and infant brain,development. This was ... of nutrition experts summarized in the September 2007,Fats of ... pregnant and lactating women to consume at least 200 ...
... Former Procter & Gamble security executive has agreed to work with ... ... Program(TM)., PRINCETON, N.J., Oct. ... channel integrity and create,business value for pharmaceutical, biotech, and medical device ...
... Care a Top ... Priority at Newton-Wellesley, RESTON, Va. ... today announced Newton-Wellesley,s use of,the Isabel decision support system to ... care, the implementation,kicks off an initiative to affirm the quality ...
Cached Medicine News:Health News:A nation divided over health care? Not so fast 2Health News:SearchMedica Finds Most Relevant and Now Most Recent Search Results 2Health News:SearchMedica Finds Most Relevant and Now Most Recent Search Results 3Health News:Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s 2Health News:IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service 2Health News:Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System 2Health News:Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System 3
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
Medicine Products: